A practical valuation guide for SLP practice owners and buyers navigating acquisitions in the $1M–$5M revenue range — covering EBITDA multiples, payer mix risk, clinician dependency, and deal structures that close.
Find Speech Therapy Practice Businesses For SaleSpeech therapy practices are primarily valued on a multiple of Seller's Discretionary Earnings (SDE) for smaller owner-operated clinics or EBITDA for practices with $1M or more in revenue and multiple employed clinicians. Valuations are heavily influenced by how independent the practice is from the founding clinician, the diversification of its payer mix across private insurance, Medicaid, school contracts, and private pay, and the stability of its licensed SLP team. Practices with 3 or more employed SLPs, recurring school district contracts, and EBITDA margins above 20% consistently command premiums in the 5x–6x range, while founder-dependent or Medicaid-heavy practices typically trade at the lower end of the range.
3.5×
Low EBITDA Multiple
4.75×
Mid EBITDA Multiple
6×
High EBITDA Multiple
Speech therapy practices in the lower middle market trade between 3.5x and 6x EBITDA. Practices at the low end typically have heavy owner clinical involvement (40%+ of billable hours), Medicaid-concentrated payer mixes, limited employed staff, or unresolved billing compliance issues. Mid-range valuations (4x–5x) reflect stable multi-therapist practices with mixed payer revenue and moderate owner independence. Premium multiples of 5.5x–6x are reserved for practices with 5+ employed SLPs, diversified referral pipelines from schools and physicians, strong EBITDA margins above 25%, telehealth infrastructure, and a clinical lead capable of operating independently of the owner.
$2,200,000
Revenue
$495,000
EBITDA
5.0x
Multiple
$2,475,000
Price
SBA 7(a) loan covering approximately $2.2M (90% of purchase price) at current prevailing SBA rates over a 10-year term; buyer equity injection of $247,500 (10%); seller note of $125,000 on 24-month standby subordinated to the SBA lender; seller transitions into a part-time clinical director role at $80,000 annually for 18 months to support referral continuity and staff retention. Practice has 4 employed SLPs, a diversified payer mix of 55% commercial insurance, 25% private pay, and 20% school district contracts, and owner currently performing 20% of billable hours.
EBITDA Multiple
The most common valuation method for speech therapy practices with $1M or more in revenue. EBITDA is calculated by adding back owner compensation above a market-rate clinical salary, personal expenses, and one-time costs to net income. The resulting normalized EBITDA is then multiplied by an industry-appropriate multiple (3.5x–6x) to arrive at enterprise value. Buyers focus heavily on the sustainability of EBITDA — particularly whether margins hold if the owner reduces or exits their clinical caseload.
Best for: Practices with $1M–$5M in revenue, multiple employed SLPs, and financial statements prepared on an accrual basis with clear owner add-backs
Seller's Discretionary Earnings (SDE)
SDE adds the owner's full compensation, benefits, and personal expenses back to net income to capture total economic benefit to a working owner-operator. This method is most appropriate for smaller practices where the owner is still the primary clinician. SDE multiples for speech therapy clinics typically range from 2.5x–4x and are used when a buyer intends to step into an active clinical or operator role rather than install a manager.
Best for: Owner-operated practices under $1M in revenue or those where a single SLP-owner generates the majority of billable revenue
Revenue Multiple
A revenue multiple approach (typically 0.5x–1.2x annual revenue) is sometimes used as a sanity check or in situations where EBITDA is temporarily suppressed by growth investments, new hire ramp-up costs, or a recent location expansion. Buyers backed by private equity roll-up platforms may anchor initial offers to revenue when building a portfolio and later reconcile to EBITDA post-normalization. This method is rarely used in isolation for final deal pricing.
Best for: Strategic acquirers conducting preliminary screening, roll-up platforms comparing multiple targets, or practices in rapid growth phases with temporarily compressed margins
Discounted Cash Flow (DCF)
DCF analysis projects future free cash flows — accounting for anticipated SLP hiring costs, reimbursement rate trends, and lease obligations — and discounts them back to present value using a risk-adjusted discount rate. In speech therapy acquisitions, DCF is most useful for modeling scenarios around Medicaid reimbursement changes or the financial impact of telehealth expansion. It is rarely used as a standalone valuation but often supports buyer underwriting when SBA lenders require forward-looking projections.
Best for: Sophisticated buyers and SBA lenders stress-testing valuation assumptions, or practices with school district contracts providing predictable multi-year cash flow visibility
Owner-Independent Clinical Team of 3+ Employed SLPs
The single most important value driver in a speech therapy practice is whether the business can generate revenue without the owner in the treatment room. Practices with 3 or more employed or contracted SLPs who carry their own independent caseloads, maintain their own patient relationships, and operate under a clinical supervisor or lead SLP command significantly higher multiples. Buyers — especially PE-backed platforms and SBA-financed acquirers — will discount aggressively or walk away entirely if more than 40% of billable hours flow through the founder.
Diversified Payer Mix Across Insurance, Private Pay, and School Contracts
A healthy payer mix insulates revenue from the reimbursement volatility that makes Medicaid-heavy practices risky to underwrite. Practices that derive revenue from a blend of commercial insurance, direct-pay families, and school district contracts demonstrate stability and often command premium multiples. School district service agreements are particularly valued because they represent recurring, contract-based revenue with institutional counterparties — a meaningful differentiator in buyer diligence.
Established Referral Pipelines from Physicians and Schools
Durable referral relationships with pediatricians, ENT specialists, neurologists, and school psychologists represent a competitive moat that transfers with the practice entity rather than the individual owner. Buyers assess whether referral sources are documented at the practice level, whether those relationships can be maintained through a transition period, and whether the practice has multiple independent referral channels rather than dependence on a single physician or school district contact.
EBITDA Margins Above 20% With Clean Financials
Speech therapy practices with EBITDA margins consistently above 20% signal operational discipline — efficient scheduling, strong collections, controlled staff-to-revenue ratios, and billing systems that minimize denials and write-offs. Clean accrual-based financials with clearly documented owner add-backs accelerate buyer due diligence and reduce deal risk, which directly supports higher multiples. Practices with commingled personal and business expenses or cash-basis accounting often face valuation haircuts even when underlying economics are strong.
Telehealth Infrastructure and Multi-Location Scalability
Practices that have successfully integrated telehealth delivery — particularly for adult dysphagia follow-up, articulation maintenance, or rural/underserved patient populations — demonstrate scalability beyond a single physical location. Buyers, especially roll-up platforms, assign premium value to practices with proven telehealth protocols, compliant billing practices for virtual services, and infrastructure that supports geographic expansion without proportional cost increases.
Long-Term School District Contracts or Government Service Agreements
Multi-year contracts with school districts or government agencies for IEP-related speech therapy services provide recurring, predictable revenue that buyers underwrite with high confidence. These agreements reduce revenue volatility, validate clinical quality through institutional procurement processes, and often serve as anchor revenue that supports SBA lender underwriting. Practices with one or more active multi-year contracts consistently receive valuation premiums relative to purely insurance-dependent peers.
Owner Performing More Than 40% of Billable Clinical Hours
When the founding SLP generates the majority of clinical revenue, buyers face an acute key-person risk that is difficult to mitigate through deal structure alone. Earnouts and transition agreements help, but lenders and acquirers both discount the enterprise value significantly when revenue is this concentrated in a single clinician. Sellers planning an exit should begin reducing their personal caseload to below 25% of total practice revenue at least 18–24 months before going to market.
Heavy Medicaid Concentration With Low Reimbursement Rates
Practices deriving more than 50–60% of revenue from Medicaid face compounding risks: low reimbursement rates that compress margins, high administrative burden from prior authorization and documentation requirements, and exposure to unpredictable state-level policy changes. Buyers and SBA lenders will apply meaningful valuation discounts or impose deal structure protections — such as revenue-based earnouts — when Medicaid concentration is high.
Outdated EHR, Billing Documentation Issues, or Unresolved Audit Exposure
Insurance billing audits, unresolved overpayment demands, or EHR documentation that does not support the CPT codes billed are serious red flags that can kill deals or trigger significant price reductions. Buyers conducting diligence will review billing histories, payer correspondence, and a sample of clinical documentation to assess compliance risk. Sellers with any audit history should resolve outstanding issues and conduct an internal billing review before entering a sale process.
Single-Location Dependency With No Telehealth or Expansion Infrastructure
A practice operating from a single leased location with no telehealth capability and no documented plan for geographic expansion presents limited upside to strategic buyers and PE platforms. Single-location concentration also creates lease risk — if the landlord declines to renew or assign the lease, the entire practice value is threatened. Buyers will discount practices that lack portability or that have lease terms expiring within 12 months of close without renewal options.
High Staff Turnover or SLP Shortage in the Local Labor Market
The national SLP workforce shortage is acute, and practices in markets with high competition for licensed clinicians face real margin compression risk as salaries rise and vacancy rates climb. Practices with documented turnover in the prior 24 months, unfilled SLP positions, or over-reliance on contract and per-diem clinicians signal operational fragility to buyers. High turnover also disrupts patient continuity and can erode referral relationships that depend on consistent clinician quality.
Referral Concentration in a Single Source or Personal Relationship
When 40% or more of new patient referrals flow from a single physician, school contact, or personal relationship tied to the owner, buyers face concentration risk that mirrors key-person dependency. If that referral relationship does not transfer with the practice — or if it deteriorates during ownership transition — revenue can decline sharply. Buyers will scrutinize referral source data in diligence and may structure earnouts specifically around referral retention milestones.
Find Speech Therapy Practice Businesses For Sale
Signal-scored targets with seller motivation, multiples, and outreach — free to join.
Most speech therapy practices in the $1M–$5M revenue range sell for 3.5x to 6x EBITDA. Where your practice lands within that range depends primarily on how owner-independent your clinical team is, how diversified your payer mix is, and whether your financials are clean and well-documented. A practice with 4+ employed SLPs, strong school and physician referral relationships, and EBITDA margins above 22% can realistically achieve 5x–6x. A practice where the owner still sees 50% of patients and has heavy Medicaid dependence will likely trade at 3.5x–4x even if revenue is strong.
Buyers start with your net income and add back owner compensation above a market-rate clinical salary (typically $90,000–$115,000 for a working SLP-owner), personal expenses run through the business, one-time costs, and non-cash charges like depreciation. The result is your normalized EBITDA — the true cash-generating power of the practice assuming a new owner steps in at a reasonable management salary. This is the number your multiple is applied to, which is why clean, well-documented financials with clear add-backs are so important to maximizing your final sale price.
Yes. Speech therapy practices are well-suited for SBA 7(a) financing. They are established cash-flow businesses with identifiable assets, recurring revenue, and strong debt service coverage in most cases. SBA lenders will typically finance up to 90% of the purchase price over a 10-year term, requiring the buyer to inject 10% equity. Lenders will scrutinize payer mix concentration, owner dependency risk, and trailing 3-year financials closely. Practices with clean compliance histories, employed clinician teams, and EBITDA margins above 18% are the strongest candidates for full SBA financing.
Significantly. If you are personally delivering more than 30–40% of billable clinical hours, buyers and lenders treat that revenue as high-risk — because it may not transfer to a new owner. This is one of the most common reasons speech therapy practices sell below their potential value. The fix is to begin transitioning your personal patients to employed SLPs 18–24 months before going to market, until your personal caseload represents less than 20–25% of total practice revenue. Every percentage point you reduce below that threshold measurably increases your valuation multiple.
Payer mix is one of the most carefully scrutinized factors in any speech therapy acquisition. Commercial insurance and private-pay revenue are valued most highly because reimbursement rates are higher and more stable. School district contracts are valued for their recurring, contractual nature. Medicaid revenue is valued least due to low reimbursement rates, high administrative burden, and policy risk. Practices with more than 50–60% Medicaid revenue typically face valuation discounts and may encounter SBA lender resistance. Diversifying your payer mix before selling — even modestly — can have a meaningful impact on your final sale price.
Most lower middle market speech therapy acquisitions use an SBA 7(a) loan as the primary financing vehicle, covering 85–90% of the purchase price with the buyer contributing 10–15% equity. Sellers frequently carry a small seller note (5–10% of price) that is placed on 18–24 month standby to satisfy SBA subordination requirements. In cases where there is owner-dependency risk or revenue uncertainty, buyers may also propose an earnout tied to revenue retention or clinician headcount milestones over the first 12–18 months post-close. Equity rollovers — where the seller retains 10–20% of the new entity — are increasingly common in PE-backed roll-up transactions.
Most speech therapy practice sales take 12–18 months from the decision to sell through final closing. The preparation phase — cleaning up financials, reducing owner caseload, organizing compliance documentation, and renewing key contracts — typically takes 6–12 months and is the most important investment a seller can make. The active marketing, diligence, and financing phase typically adds another 4–6 months. Sellers who enter the process unprepared often face extended timelines, retrades on price, or failed closings due to lender concerns about owner dependency or billing compliance.
Buyers and their lenders will scrutinize five core areas: payer mix and reimbursement sustainability, clinician licensure and staff retention risk post-close, HIPAA compliance and billing audit history, the durability of referral relationships with schools and physicians, and the degree to which the owner's personal caseload drives revenue. Strong practices will have 3 years of clean accrual financials, current SLP licensure on file for all clinical staff, documented referral source relationships tied to the practice entity, an up-to-date EHR and billing compliance record, and an office manager or clinical lead capable of operating independently.
More Speech Therapy Practice Guides
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers